Immunohistochemistry and PET studies have shown reduced P-gp expression and activity in patients with AD [16–18, 64, 65]; however, P-gp expression in the brain capillaries was stable in APP-KI mice in our study. This evidence concerns the gene APP and Alzheimer disease.